These results suggest that IgA, but not IgG against Fn possess diagnostic capabilities for CRC, and anti-Fn-IgA increases the sensitivity in CRC detection and offers additional diagnosis value in CRC. This evidence concerns the gene FN1 and colorectal carcinoma.